|
|
News Breaks | | | | December 27, 2012 | | 07:31 EDT |  | CNDO | Coronado Biosciences acquires TSO manufacturing rights from Ovamed
Coronado Biosciences announced the acquisition of manufacturing rights to its lead product TSO, or Trichuris suis ova or CNDO-201, from Ovamed GmbH, for North America, South America, and Japan, Coronado's licensed territory. As part of the transaction, Coronado entered into a lease agreement to establish a manufacturing facility in Woburn, MA to produce TSO. Under the amendments, Coronado will pay Ovamed a total of $1.5M in three equal installments in 2014-2016, and, in lieu of product supply payments that would have been payable to Ovamed as the exclusive supplier, certain fees for product manufactured and sold by Coronado. | |
|
News For CNDO From The Last 14 Days Check below for free stories on CNDO the last two weeks. |
|
|
| May 8, 2013 | | 07:23 EDT |  | CNDO | Coronado Biosciences reports Q1 EPS (35c), consensus (30c)
 Subscribe for More Information | |
|
|
|
|
|
|
